|
|
||||||||
Biology of Reproduction, Vol 14, 202-211, Copyright © 1976 by Society for the Study of Reproduction
1 Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts 01545 The fertilizing ability of epididymal spermatozoa from rats and mice treated with various doses
of CL-88,236 and AY-22,352 was tested in vitro or in vivo by intrauterine insemination. None of
the eggs were fertilized in either test system by spermatozoa from rats treated daily with 14.7 mg
CL-88,236 or 50.5 mg AY-22,352/kg/day for 3 to 4 days. At lower doses, significantly fewer eggs
were fertilized in vitro and in vivo by spermatozoa from rats treated daily with 0.88 to 8.8 mg
CL-88,236 for 3 to 4 days, and in vitro or in vivo by spermatozoa from rats treated with 8.4 to
25.3 mg AY-22,352/kg/day for 3 days as compared with the number of eggs fertilized in the
corresponding control. In the mouse, daily treatment with approximately 88.4 mg
CL-88,236/kg/day was required to inhibit the fertilizing capacity of spermatozoa as judged by in
vitro tests. By contrast, the fertilizing capacity of spermatozoa in vivo was not reduced by
spermatozoa from mice that received even 353.6 mg CL-88,236/kg/day for 3 days. But daily
treatment of mice with more than 10.1 mg AY-22,352/kg/day reduced significantly the fertilizing
capacity of spermatozoa in vitro and in vivo.
Note:
ACKNOWLEDGMENTS
This work was supported by a grant (HD 03472)
from the U.S. Public Health Service, a grant from the
Ford Foundation, and a small contract from the
Human Reproduction Unit, World Health Organization. One of us (M.C.C.) is a Research Career Awardee
(K6-HD-18,334) of the National Institute of Child
Health and Human Development. Thanks are due to
Dr. E. C. DeRenzo of Lederle Laboratories for the
supply of CL-88,236, to Dr. U. K. Banik of Ayerst
Laboratories for the supply of AY-22,352 and to Mrs.
Rose Bartke for assistance.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |